Neuronal migration disorders: A cause of curable medication resistant epilepsy;Alteraciones de la migración neuronal: Una causa de epilepsia farmacorresistente curable

Revista de Neurologia

Volumn 43, Issue 1, 2006, Pages 20-24

  Piñol Ripoll, Gerard ^a   Mauri Llerda, J A ^a   Rumia J ^b   Carreno M ^b   De La Puerta Gonzalez Miro I ^a   Mostacero Miguel, E ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Epilepsy surgery; Focal cortical dysplasia; Frontal seizures; Magnetic resonance imaging; Medication resistant epilepsy; Neuronal migration disorders

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CORTICOSTEROID; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL DYSPLASIA; ELECTROENCEPHALOGRAM; EPILEPSY; HUMAN; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NEURONAL MIGRATION DISORDER; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIKE WAVE; BRAIN DISEASE; CELL MOTION; CYTOLOGY; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTICONVULSANTS; BRAIN DISEASES; CELL MOVEMENT; EPILEPSY; HUMANS; MALE; NEURONS;

EID: 33750103087     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4301.2005661     Document Type: Article

References (30)

1. Meschede F. Ueber neubildung grauer hirnsubstanz in den wandungen der seiten-ventrikel und über eine bisher nicht beschriebene, durch hyperplase grauer cortical substanz bedingte struktur-anomalie der hirnrinde. Allg Z Psychiatr 1864; 21: 481-505.
2. Virchow R. Zur pathologischen anatomie des gehirns. Heterotopie der grauer hirnsubstanz. Arch Pathol Anat Psysiol 1867; 38: 138-42.
3. Ramón y Cajal S. Histologie du système nerveux de l'homme et des vertébrés. Vol. 2. Paris: Malonie; 1911. p. 847-61.
4. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex epilepsy. J Neurol Neurosurg Psychiatry 1971; 34: 369-87.
5. Raymond A, Fish D, Sisodiya S, Alsanjari N, Stevens J, Shorvon S. Abnormalities of gyration, heterotipias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembrioplastic neuroepithelial tumour, and dysgenesis of the archicortex in epilepsy. Clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995; 118: 629-60.
6. Campos-Castelló J, López-Lafuente A, Ramírez-Segura R, Martínez-Hernández C, De Santos-Moreno MT. Manifestaciones epilépticas en las alteraciones de la migración neuronal. Rev Neurol 1999; 28 (Supl 1): S14-9.
7. Palmini A, Andermann F, De Grissac H, Tampieri D, Robitaille Y, Langevin P, et al. Stages and patterns of centrifugal arrest of difuse neuronal migration disorders. Dev Med Child Neurol 1993; 35: 331-9.
8. Kuzniecky R, Berkovic S, Andermann F, Melanson D, Olivier A, Robitaille Y. Focal cortical myoclonus and rolandic cortical dysplasia: clarification by magnetic resonance imaging. Ann Neurol 1988; 23: 317-25.
9. Aicardi J. Diseases of the nervous system: I. Chilhood. Clinics in Developmental Medicine, 115-118. Oxford: MacKeith Press/Blackwell Science; 1992. p. 144-72.
10. Forcadas-Berdusán MI. Problemas diagnósticos y tratamiento de las epilepsias frontales. Rev Neurol 2002; 35 (Supl 1): S42-6.
11. Hattern M, Mason C. Mechanisms of glial-guided neuronal migration in vitro and in vivo. Experientia 1990; 46: 907-16.
12. Rakic P. Principles of neuronal cell migration. Experientia 1990; 46: 882-91.
13. Barth PG. Fetal disruption as cause of neuronal migration defects. In Barth PG, ed. Disorders of neuronal migration. International Review of Child Neurology Series. London: McKeith Press; 2003. p. 182-194.
14. Eriksson SH, Thom M, Hefferman J, Lin WR, Harding BN, Squier MV. Persistent reelin-expressing Cajal-Retzius cells in polymicrogyria. Brain 2001; 124: 1350-61.
15. Sarnat HB, Flores-Sarnat L. Cajal-Reztzius and subplate neurons: their role in cortical development. Eur J Paediatr Neurol 2002; 6: 91-7.
16. Mischel PS, Vinters HV. Neuropathology of developmental disorders associated with epilepsy. In Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven; 1997. p. 119-31.
17. Scully RE, Mark EJ, McNeely WF, Ebeling SH. Case records of the Massachusetts General Hospital. Case 6-1997. N Engl J Med 1996; 29: 586-92.
18. Garbelli R, Munari C, De-Biasi S, Vitellaro-Zuccarello L, Galli C, Bramerio M, et al. Taylor's cortical dysplasia: a confocal and ultrastructural immunohistochemical study. Brain Pathol 1999; 9: 445-61.
19. Lee BC, Schmidt RE, Hatfield GA, Bourgeois B, Park TS. MRI of focal cortical dysplasia. Neuroradiology 1998; 40: 675-83.
20. Barluenga E, Rovira A. Displasia cortical focal. Rev Neurol 1997; 25: 136.
21. Kuzniecky R, Garcia JH, Faught E, Morawtz RB. Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol 1991; 29: 293-8.
22. Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y, Andermann E, et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol 1991; 30: 741-9.
23. Kuzniecky R, Mountz JM, Wheatley G, Morawetz R. Ictal single-photon emission computed tomography demonstrates localized epileptogenesis in cortical dysplasia. Ann Neurol 1993; 34: 627-31.
24. Otsubo H, Hwang PA, Hoffman HJ, Becker LE, Gilday DL, Chunag SH, et al. Neuroimaging studies in children with tamporal lobectomy. Childs Nerv Syst 1995; 11: 281-7.
25. 99mTc-HMPAO SPECT. Neurology 1993; 43: 1966-80.
26. Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodiya SM, Shorvon SD. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology 1994; 44: 1841-45.
27. Cendes F, Cook MJ, Watson C, Andermann F, Fish DR, Shorvon SD, et al. Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 1995; 45; 2058-64.
28. Ho SS, Kuzniecky RI, Gilliam F, Faught E, Morawtz R. Temporal lobe development malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology 1998; 50: 748-54.
29. Sánchez-Álvarez JC, Altuzarra-Corral A, Mercadé-Cerdà JM, Casado-Chocán JL, Moreno-Alegre V, Rufo-Campos M, et al. Guía terapéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: IV. Principios generales de politerapia antiepiléptica y estrategias terapéuticas en epilepsia refractaria. Rev Neurol 2005; 40: 743-50.
30. Li LM, Cendes F, Andermann F, Watson C, Fish DR, Cook MJ, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999; 122 (Pt 5): 799-805.